The US FDA has provided further clarification on Neurizon’s IND application for NUZ-001. ... Read More The post ‘One straightforward request’: Neurizon buoyant on FDA clarity appeared first on ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...